Latest news with #Zig-Zag
Business Upturn
09-07-2025
- Business
- Business Upturn
Zig-Zag Launches New Premium Natural Leaf Cigar Line – Zig-Zag Woods
By GlobeNewswire Published on July 9, 2025, 02:53 IST Los Angeles, California, July 08, 2025 (GLOBE NEWSWIRE) — Zig-Zag Launches New Premium Natural Leaf Cigar Line – Zig-Zag Woods Slow-Burning, Boldly Flavored, and Value-Priced for High Turnover in Convenience and Smoke Shop Channels Zig-Zag, a heritage brand trusted by millions, proudly announces the launch of Zig-Zag Woods, a new line of premium natural leaf cigars crafted for today's adult cigar consumer and strategically designed for convenience stores and smoke shops. With more than 58% of consumers referring to rough-cut cigars as 'woods', this launch meets consumer expectations with a name and format that resonates. Zig-Zag Woods features a slow-burning, all-natural leaf wrap filled with premium rough-cut tobacco, delivering a rich and smooth smoking experience. With bold flavor profiles and recognizable Zig-Zag branding, this line is engineered for fast sell-through and high margins. Over 300 million rough-cut cigars are sold annually (MSA), demonstrating the strength of this segment, and Zig-Zag Woods is primed to compete and win. Product Offering: 5 Varieties: Natural Silk & Berries Sweet Aromatic Crème Royale Velvet Pre-Priced: $1.39 for 2 cigars $1.39 for 2 cigars Packaging Configuration: 15 pouches per carton 24 cartons per case Whether your customers prefer the boldness of Sweet Aromatic or the smoothness of Velvet, Zig-Zag Woods provides a flavor for every taste. With its competitive price point, premium quality, and shelf-ready format, Zig-Zag Woods is primed to become a top seller in the natural leaf cigar segment. 'Customers have been asking for a premium value-added product that moves quickly and satisfies customers. Zig-Zag Woods is our answer,' said Jessica Chesney, SBM of Marketing at Zig-Zag. 'We've combined quality, flavor variety, and value into a package that's a win for both consumers and the trade.' Now Shipping Nationwide Zig-Zag Woods are now available for wholesale and retail ordering. For more information, promotional assets, or to place an order, contact Zig-Zag customer service at (800) 331-5962 [email protected] or visit TPB Marketplace. About Zig-Zag Zig-Zag is a market leader in premium tobacco and smoking accessories, known for its authenticity, innovation, and quality. With a legacy spanning over 140 years, Zig-Zag continues to evolve with consumer trends while delivering reliable products to its retail partners. Zig-Zag is exclusively distributed by Turning Point Brands (NYSE: TPB), a manufacturer, marketer, and distributor of branded consumer products. Attachment Zig-Zag Launches New Premium Natural Leaf Cigar Line – Zig-Zag Woods Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
23-04-2025
- Business
- Yahoo
Turning Point Brands to Host Q1 Conference Call
LOUISVILLE, Ky., April 23, 2025--(BUSINESS WIRE)--Turning Point Brands, Inc. (NYSE: TPB) announced the date and time for its conference call to review 1st quarter 2025 results. The conference call will be on Wednesday, May 7, 2025 at 9:30 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free)(646) 307-1963 (International)Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at The replay of the webcast will be available on the site two hours following the call. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker's®, FRE®, and ALP®. TPB's products are available in more than 220,000 retail outlets in North America and on sites such as and For the latest news and information about TPB and its brands, please visit View source version on Contacts ir@ Sign in to access your portfolio
Yahoo
22-03-2025
- Business
- Yahoo
TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we'll examine three profitable and cheap cannabis-related stocks that offer investors long-term value and potential upside: Turning Point Brands (TPB), Aurora Cannabis (ACB), and Jazz Pharmaceuticals (JAZZ). Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Having been illegal for decades, cannabis is seeing the light of day following spates of deregulation across the U.S., Canada, Australia, and Europe over the past decade. Cannabis stocks, otherwise known as pot stocks, have understandably emerged to mop up the huge pent-up demand for cannabis products. Whether it be medicinal, industrial, or recreational, the cannabis market is now a commercial entity being monetized across the U.S. and Canada. In the U.S., after an initial sentiment boost following legalization, the cannabis market has cooled. The AdvisorShares Pure US Cannabis ETF (MJUS), which tracks U.S. cannabis stocks, traded at over $50 a share in early 2021 but now trades for just $2.68. Tilray Brands (TLRY), one of the earliest and most hyped pure-play publicly traded cannabis companies, traded for over $145 a share in late 2018 but today is priced at less than a dollar. It's hard to understate how poorly many of these pure-play cannabis stocks have performed. While it has been a difficult space to invest in, the industry still harbors potential — recreational marijuana is now legal in 24 U.S. states (plus Washington D.C.), while medical marijuana is legal in 39 (that said, it's important to note that it is still classified as a Schedule 1 Drug by the Federal Government). Grand View Research predicts the global legal cannabis market will grow to $102 billion by 2030, suitable for an impressive 25.5% CAGR. For investors still interested in the industry and gaining exposure to the space, the good news is that the sector has matured, and there are plenty of innovative ways to invest in it rather than speculating on questionable stocks with little earnings. Turning Point Brands (TPB) is an interesting way to enter the cannabis space. While it is not a pure-play cannabis company, it sells Zig-Zag rolling papers and is part of the industry. It is also included in New Cannabis Ventures' Global Cannabis Stock Index. Unlike many of its peers, it has performed quite well, nearly doubling over the past year. However, unlike some of these peers, Turning Point is profitable, and even after this massive rally, it is actually reasonably cheap, trading for under 19x 2025 earnings estimates, a slight discount to the broader market. Turning Point offers both momentum and value and has much potential going forward. In addition to rolling papers, the company sells nicotine pouches under the FRE brand. Most notably, last year, Turning Point launched a high-profile 50/50 joint venture with Tucker Carlson Media to start a new nicotine pouch brand called ALP. This move garnered significant publicity as Tucker Carlson has a significant following as one of the most popular (if polarizing) figures in U.S. media, giving ALP a large platform and high visibility. Nicotine pouches have rapidly gained popularity in recent years, with products like Zyn becoming a major hit for Philip Morris (PM). Between the popularity of nicotine pouches and Carlson's ability to sell ALP to his audience, ALP has a lot of growth potential going forward. I like Turning Point as a smart way to play the cannabis space because it offers strong diversification. Investors get exposure to cannabis through Zig-Zag and diversification into other revenue streams thanks to its nicotine pouch businesses. On Wall Street, TPB earns a Strong Buy consensus rating based on three Buys, zero Holds, and zero Sell ratings assigned in the past three months. The average analyst TPB stock price target of $81.67 implies a 43% upside potential from current levels. Aurora Cannabis was among the buzziest stocks of the initial cannabis stock boom, reaching nearly $150 a share in 2021. However, the stock has fallen precipitously since then, losing nearly 95% of its value over the past five years. However, there are some green shoots of life here. After years of losses, the stock is up nearly 20% over the past year. The company recently reported a record adjusted EBITDA of $7 million last quarter as its pivot from focusing on the Canadian recreational market to the more lucrative and high-margin international medical market began to bear fruit. This was evidenced by revenue from the global market surging 93% and surpassing Canadian revenue for the first time. In addition to becoming profitable, Aurora is also reasonably cheap—shares trade for a very reasonable 17.8x 2025 earnings. While this is still a speculative stock based on its spotty history, its valuation and swing to record profitability based on its strategic shift make it an intriguing speculative opportunity for risk-averse investors. Plus, sell-side analysts foresee monster upside potential ahead. Turning to Wall Street, ACB earns a Moderate Buy consensus rating based on two Buys, one Hold, and zero Sell ratings assigned in the past three months. The average analyst ACB stock price target of $7.10 implies a 58% upside potential from current levels. Lastly, let's examine Jazz Pharmaceuticals ($ JAZZ) as a different way to gain exposure to the cannabis market. To be clear, Jazz Pharmaceuticals is not a pure play on cannabis as it is a diversified biotech company with an $8.5 billion market cap. However, it offers significant exposure to cannabis thanks to its 2021 acquisition of GW Pharmaceuticals, which added CBD-based epilepsy drug Epidiolex to its portfolio. The successful drug is now approaching $1 billion in annual sales and is approved in dozens of countries worldwide. In addition to Epidiolex, Jazz's product portfolio includes many other drugs focused on sleep disorders and oncology. I like that this gives investors diversification and additional revenue streams outside of cannabis. What's more, shares of Jazz are pretty cheap. With analysts projecting the company to earn $23.42 per share in 2025, the stock trades for just six times 2025 earnings estimates. Turning to Wall Street, JAZZ earns a Strong Buy consensus rating based on seventeen Buys, one Hold, and zero Sell ratings assigned in the past three months. The average analyst JAZZ stock price target of $193.82 implies a 40% upside potential from current levels. While many cannabis stocks have developed a bad reputation after falling drastically from their lofty 2021 highs, there are pockets of value here if you know where to look. Many weaker players have gone by the wayside, while the stronger companies have matured and become more profitable. I like Turning Point Brands, Aurora Cannabis, and Jazz Pharmaceuticals as three attractive ways to play the market — all three are quite different, but what they have in common is that they are all profitable, and they all trade for inexpensive valuations. Furthermore, analysts project a significant potential upside of over 40% or more for all three over the next 12 months, highlighting their strong potential. Disclosure Questions or Comments about the article? Write to editor@ Sign in to access your portfolio
